Antineoplaston A10(b)

CAS No. 91531-30-5

Antineoplaston A10(b)( NSC-648539 )

Catalog No. M20619 CAS No. 91531-30-5

Antineoplaston A 10 is a Ras inhibitor potentially for the treatment of glioma lymphoma astrocytoma and breast cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 98 In Stock
10MG 165 In Stock
25MG 323 In Stock
50MG 492 In Stock
100MG 709 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Antineoplaston A10(b)
  • Note
    Research use only, not for human use.
  • Brief Description
    Antineoplaston A 10 is a Ras inhibitor potentially for the treatment of glioma lymphoma astrocytoma and breast cancer.
  • Description
    Antineoplaston A 10 is a Ras inhibitor potentially for the treatment of glioma lymphoma astrocytoma and breast cancer.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NSC-648539
  • Pathway
    MAPK/ERK Signaling
  • Target
    Ras
  • Recptor
    Ras
  • Research Area
    Cancer
  • Indication
    Anaplastic astrocytoma; Glioma

Chemical Information

  • CAS Number
    91531-30-5
  • Formula Weight
    246.26
  • Molecular Formula
    C13H14N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (1015.19 mM)
  • SMILES
    O=C(Cc1ccccc1)N[C@H]1CCC(=O)NC1=O
  • Chemical Name
    N-[(3S)-26-dioxopiperidin-3-yl]-2-phenylacetamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Qu X J Cui S X Tian Z et al. Induction of apoptosis in human hepatocellular carcinoma cells by synthetic antineoplaston A10[J]. Anticancer Research 2007 27(4B):2427.
molnova catalog
related products
  • pan-Ras inhibitor 31...

    pan-Ras inhibitor 3144 (Compound 3144) is a multivalent small-molecule, pan-RAS inhibitor.

  • KRas-IN-1

    A chemical fragment hit that binds to K-Ras (G12D) with affinities of 1.3-2 mM.

  • ARS-1620

    ARS-1620 is a potent, specific and covalent KRAS G12C inhibitor.